The compound consists of four amino acids: alanine, glutamic acid, aspartic acid, and glycine, arranged in a specific sequence
13% of the participants treated with the combined compound ended up discontinuing the trial, while 10% of the participants treated with semaglutide discontinued, however, none of the participants treated with cagrilintide discontinued their treatment plan indicating that cagrilintide was the most well tolerated by the study participants [2]
127 RothCLScimiaCShoemakerAHGottschalkMMillerJYuanGet al
Elegant textures designed for absorption and performance
Cagrilintide is a synthetic long-acting amylin analogue peptide studied alongside GLP-1 pathway research
Researchers continue to investigate BPC-157 across a variety of laboratory models to better understand its biological activity and interactions with different cellular systems